Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia: Case report and literature review

Endocrine Practice

Volumn 17, Issue 2, 2011, Pages

  Holmes, George I ^a   Shepherd, Pat ^b   Walker, James D ^a  

^a ST JOHN'S HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; HYDROCORTISONE; LEVOTHYROXINE; PROLACTIN; TESTOSTERONE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PHYSICAL EXAMINATION; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

EID: 79959228043     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10298.CR     Document Type: Article

References (26)

1. Nishioka H, Haraoka J. Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine. J Endocrinol Invest. 2005;28:528-533. (Pubitemid 43162886)
2. Erslev AJ. Anemia of endocrine disorders. In: Ernest B, Marshall AL, Barry SC, Thomas JK, eds. Williams Hematology. 6th ed. New York, NY: McGraw-Hill, 2001: 407-411.
3. Bloom A, Bryson CC. Aplastic anaemia in Simmonds's disease: report of a case. Br Med J. 1948;2:75-77.
4. Ferrari E, Ascari E, Bossolo PA, Barosi G. Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol. 1976;33:575-582.
5. Kim SK, Oh YJ, Joo PY, et al. A case of pancytopenia caused by Sheehan's syndrome improved with hormone replacement therapy. J Korean Soc Endocrinol. 2000;15: 595-599.
6. Kim DY, Kim JH, Park YJ, et al. Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol. 2004;83:309-312. (Pubitemid 38594330)
7. Ozdogan M, Yazicioglu G, Karadogan I, Cevikol C, Karayalcin U, Undar L. Sheehan's syndrome associated with pancytopenia due to marrow aplasia: full recovery with hormone replacement therapy. Int J Clin Pract. 2004; 58:533-535. (Pubitemid 38786580)
8. Gokmen Akoz A, Atmaca H, Ustundag Y, Ozdamar SO. An unusual case of pancytopenia associated with Sheehan's syndrome. Ann Hematol. 2007;86:307-308. (Pubitemid 46351411)
9. Atmaca H, Bayraktaroglu T, Gokmen Akoz A, Koyuncu BU. Two unusual cases of pancytopenia associated with Sheehan's syndrome. Endocrine Abstracts. 2008;16:P151.
10. Laway BA, Bhat JR, Mir SA, Khan RS, Lone MI, Zargar AH. Sheehan's syndrome with pancytopenia\complete recovery after hormone replacement (case series with review). Ann Hematol. 2010;89:305-308.
11. Badawi MA, Salih F, Al-Humaidi AA, El Khalifa MY, Elhadd TA. Bone marrow hypoplasia responsive to testosterone therapy in a patient with panhypopituitarism: need for adherence to androgen replacement. Endocr Pract. 2008;14:229-232.
12. Killmann SA. A case of pancytopenia in hypopituitarism: with a review of the hematological changes in clinical and experimental pituitary insuffciency. Acta Haematol. 1956; 15:34-45.
13. Song SH, McCallum CJ, Campbell IW. Hypoplastic anaemia complicating myxoedema coma. Scot Med J. 1998;43:149-150. (Pubitemid 28523900)
14. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-273. (Pubitemid 44079693)
15. MacLean FR, Hanley JP. Prolactinoma presenting as chronic anaemia with osteoporosis: a case report. J Med Case Reports. 2010;4:33.
16. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28:81-117, vi. (Pubitemid 29164779)
17. Moriyama Y, Fisher JW. Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures. Blood. 1975;45:665-670.
18. Dainiak N, Hoffman R, Maffei LA, Forget BG. Potentiation of human erythropoiesis in vitro by thyroid hormone. Nature. 1978;272:260-262. (Pubitemid 8284694)
19. Merchav S, Tatarsky I, Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Br J Haematol. 1988; 70:267-271. (Pubitemid 18265242)
20. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J Haematol. 1989;71:457-462. (Pubitemid 19121325)
21. Welniak LA, Richards SM, Murphy WJ. Effects of pro-lactin on hematopoiesis. Lupus. 2001;10:700-705.
22. Woody MA, Welniak LA, Sun R, et al. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp Hematol. 1999;27:811-816. (Pubitemid 29231018)
23. Horseman ND, Zhao W, Montecino-Rodriguez E, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926-6935. (Pubitemid 27520793)
24. Jepson JH, McGarry EE. Effect of the anabolic protein hormone prolactin on human erythropoiesis. J Clin Pharmacol. 1974;14:296-300.
25. Abkowitz JL, Schaison G, Boulad F, et al. Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis. Blood. 2002;100: 2687-2691.
26. Bellone G, Rollino C, Borsa S, et al. Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients. Proc Soc Exp Biol Med. 2000;223: 367-371. (Pubitemid 30180784)